Abstract:Khadiga SM Salama, 1 Eman M Moazen, 1 Sawsan B Elsawy, 1 Sanaa F Kotb, 1 Eid M Mohammed, 2 Sara A Tahoun, 3 Marwa A A Ramadan, 3 Samar M Abd Elhamid, 3 Rania H M Bahi, 4 Etemad A Mohammad 5 1 Chest Diseases Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 2 Chest Diseases Department Faculty of Medicine for Men's, Al-Azhar University, Cairo, Egypt; 3 Clinical Pathology Department Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 4 Chest Diseases Department Faculty of Medicine, Zagazig University, Zagazig, Egypt; 5 Chest Diseases Department Faculty of Medicine, Benha University, Benha, Egypt Correspondence: Sawsan B Elsawy, Chest Diseases Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt, Email Background and Aim: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has profound effects on disease progression and patients' quality of life. Emerging evidence suggests an association between alterations in the respiratory microbiome flora species and airway inflammation in patients with AECOPD. The present study aimed to describe the inflammatory cells and bacterial microbiome distributions in respiratory tract in Egyptian patients with AECOPD. Subjects and Methods: The present cross-sectional study included 208 patients with AECOPD. Sputum and broncho-alveolar lavage samples from the studied patients were submitted to microbial cultures using appropriate media. Total and differential leukocytic counts and were done via automated cell counter. Results: The present study included 208 AECOPD patients. They comprised 167 males (80.3%) and 41 females (19.7%) with an age of 57.9 ± 4.9 years. AECOPD was categorized as mild, moderate and severe in 30.8%, 43.3% and 26%, respectively. Sputum samples had significantly higher TLC, neutrophil percent and eosinophil percent when compared with BAL samples. In contrast, lymphocyte percent was significantly higher in BAL samples. Sputum specimens had significantly lower frequency of positive growths (70.2% versus 86.5%, p = 0.001). Among the identified organisms, sputum specimens had significantly lower frequency of Strept. pneumoniae (14.4% versus 30.3%, p = 0.001), Klebsiella pneumoniae (19.7% versus 31.7%, p = 0.024), Haemophilus influenzae (12.5% versus 26.9%, p = 0.011), Pseudomonas aeruginosa (2.9% versus 10%, p = 0.019) and Acinetobacter spp . (1.9% versus 7.2%, p = 0.012) growths when compared with BAL samples. Conclusion: The present study could identify a distinctive pattern of inflammatory cell distribution in sputum and BAL samples of AECOPD patients. The most commonly isolated organisms were Klebsiella pneumoniae and Strept. pneumoniae . Keywords: chronic obstructive pulmonary disease, COPD exacerbation, inflammatory cells, bacterial microbiome, sputum culture, bronchoalveolar culture Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity. It is one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle-income countries. 1,2 Airways of almost 50% of stable COPD patients are colonized by potentially pathogenic microorganisms (PPMs). The most commonly isolated microbes are H. influenzae, M. catarrhalis, S. pneumoniae, S. aureus, and P. aeruginosa . 3 Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an acute and sustained worsening of a patient's condition from a stable state. 4 Possible risk factors include air pollution, seasonal change, ethnic background, associated comorbidities, poor exercise capacity and obesity. 5 Management strategy usually includes bronchodilators and corticosteroids as first-line treatments. In patients with severe exacerbations, noninvasive ventilation, magnesium, ketamine, and epinephrine may be considered. Mechanical ventilation may be needed in selected situations. 6 AECOPD has profound effects on disease progression and patients' quality of life. Prevention of early recurrence and identification of causative agents remains one of the top unmet needs in management of AECOPD. 7 Remarkably, newly developed vaccines against the most frequent bacteria identified in AECOPD are assessed by undergoing trials. 8 Emerging evidence suggests an association between alterations in the respiratory microbial flora species and airway inflammation in patients with AECOPD. 9 Identification of respiratory microbiome has been increasingly recognized as a cornerstone in a modern management direction of AEC -Abstract Truncated-

Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

Lung Microbiome Dynamics in COPD Exacerbations.

Sputum Microbiome Temporal Variability and Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: an Analysis of the COPDMAP Study

Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study

Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis

The sputum microbiome is distinct between COPD and health, independent of smoking history

Dynamic microbial changes in exacerbation of chronic obstructive pulmonary disease

Characteristics of the Sputum Microbiome in COPD Exacerbations and Correlations Between Clinical Indices

Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations

Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study

Frequent Exacerbators of Chronic Obstructive Pulmonary Disease Have Distinguishable Sputum Microbiome Signatures During Clinical Stability

Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state

A Refined View of Airway Microbiome in Chronic Obstructive Pulmonary Disease at Species and Strain-Levels.

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease

Bacterial Species and Inflammatory Cell Variability in Respiratory Tracts of Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Multicentric Study

Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations

The Sputum Microbiome Associated with Different Sub-Types of AECOPD in a Chinese Cohort

Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity

Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.